Scientific article
OA Policy
English

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

Published inScientific reports, vol. 12, no. 1, 20373
Publication date2022-11-27
First online date2022-11-27
Abstract

Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65-84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.

Keywords
  • Humans
  • Aged
  • Aged, 80 and over
  • Antibodies, Neutralizing
  • SARS-CoV-2 / genetics
  • Neutralization Tests
  • Antibodies, Viral
  • RNA, Messenger
  • Viral Vaccines
  • COVID-19 / prevention & control
  • Vaccination
Citation (ISO format)
DURIER, Christine et al. Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. In: Scientific reports, 2022, vol. 12, n° 1, p. 20373. doi: 10.1038/s41598-022-24409-w
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2045-2322
64views
7downloads

Technical informations

Creation09/12/2023 10:00:39 AM
First validation12/15/2023 8:48:16 AM
Update time12/15/2023 8:48:16 AM
Status update12/15/2023 8:48:16 AM
Last indexation11/01/2024 7:02:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack